Reducing the Carbon Footprint of Neovascular Age-Related Macular Degeneration Therapy: Environmental Impact of Transitioning to Aflibercept 8 mg. [PDF]
Veritti D +9 more
europepmc +1 more source
Early Outcome Analysis of Intravitreal Aflibercept 8 mg Treatment in Naïve Patients with Neovascular Age-Related Macular Degeneration Using Artificial Intelligence. [PDF]
Bartolomeo N +6 more
europepmc +1 more source
Radiation-Associated Aortocolonic Fistula in Urothelial Carcinoma: Multidisciplinary Management and Case Report. [PDF]
Lee M +5 more
europepmc +1 more source
Sotatercept in Pulmonary Arterial Hypertension: Molecular Mechanisms, Clinical Evidence, and Emerging Role in Reverse Remodelling. [PDF]
Tilea I +4 more
europepmc +1 more source
Comparing human vs. machine-assisted analysis to develop a new approach for Big Qualitative Data Analysis. [PDF]
Martin S +10 more
europepmc +1 more source
Understanding the PULSAR effect in combined radiotherapy and immunotherapy using transformer-based attention mechanisms. [PDF]
Peng H +4 more
europepmc +1 more source
Early Outcomes of Intravitreal Aflibercept 8 mg in Eyes Previously Treated with Aflibercept 2 mg for Neovascular Age-Related Macular Degeneration with AI-Based Biomarker Quantification. [PDF]
Bartolomeo N +7 more
europepmc +1 more source
LISTEN: lived experiences of Long COVID: a social media analysis of mental health and supplement use. [PDF]
Martin S +8 more
europepmc +1 more source
Sotatercept: A First-In-Class Activin Signaling Inhibitor for Pulmonary Arterial Hypertension. [PDF]
Miranda AC +3 more
europepmc +1 more source
Aflibercept 8 mg in Neovascular AMD-A Fast-Drying Anti-VEGF Drug: A Prospective Morpho-Functional Pilot Study. [PDF]
Rinaldi M +6 more
europepmc +1 more source

